inclusion criteria: 1. age 18 and older, male or female 2. previous confirmed diagnosis of sars-cov-2 3. experiencing sars-cov-2 post-viral fatigue syndrome 4 weeks after recovery for sars-cov-2 4. experiencing neurological symptoms including fatigue 5. willing to comply with all aspects of the protocol, including blood draws 6. patient is able to understand and fully participate in the activities of the study and the consent in accordance with guidelines 7. female patients of childbearing potential who are sexually active must be willing to use an acceptable form of contraception. acceptable forms of contraception are defined as those with a failure rate of \< 1% when properly applied and include: a combination pill, some intra-uterine devices, and a sterilized partner in a stable relationship. female patients must not be pregnant, planning to become pregnant, or be actively breastfeeding through the entire period.

inclusion criteria: 1. age 18 and older, male or female 2. previous confirmed diagnosis of sars-cov-2 3. experiencing sars-cov-2 post-viral fatigue syndrome 4 weeks after recovery for sars-cov-2 4. experiencing neurological symptoms including fatigue 5. willing to comply with all aspects of the protocol, including blood draws 6. patient is able to understand and fully participate in the activities of the study and the consent in accordance with guidelines 7. female patients of childbearing potential who are sexually active must be willing to use an acceptable form of contraception. acceptable forms of contraception are defined as those with a failure rate of \< 1% when properly applied and include: a combination pill, some intra-uterine devices, and a sterilized partner in a stable relationship. female patients must not be pregnant, planning to become pregnant, or be actively breastfeeding through the entire period.

inclusion criteria: age 18 and older, male or female previous confirmed diagnosis of sars-cov-2 experiencing sars-cov-2 post-viral fatigue syndrome 4 weeks after recovery for sars-cov-2 experiencing neurological symptoms including fatigue willing to comply with all aspects of the protocol, including blood draws patient is able to understand and fully participate in the activities of the study and the consent in accordance with guidelines female patients of childbearing potential who are sexually active must be willing to use an acceptable form of contraception. acceptable forms of contraception are defined as those with a failure rate of < 1% when properly applied and include: a combination pill, some intra-uterine devices, and a sterilized partner in a stable relationship. female patients must not be pregnant, planning to become pregnant, or be actively breastfeeding through the entire period.

inclusion criteria: age 18 and older, male or female previous confirmed diagnosis of sars-cov-2 experiencing sars-cov-2 post-viral fatigue syndrome 4 weeks after recovery for sars-cov-2 experiencing neurological symptoms including fatigue willing to comply with all aspects of the protocol, including blood draws patient is able to understand and fully participate in the activities of the study and the consent in accordance with guidelines female patients of childbearing potential who are sexually active must be willing to use an acceptable form of contraception. acceptable forms of contraception are defined as those with a failure rate of < 1% when properly applied and include: a combination pill, some intra-uterine devices, and a sterilized partner in a stable relationship. female patients must not be pregnant, planning to become pregnant, or be actively breastfeeding through the entire period.

inclusion criteria: 1. age 18 and older, male or female 2. previous confirmed diagnosis of sars-cov-2 3. experiencing sars-cov-2 post-viral fatigue syndrome 4 weeks after recovery for sars-cov-2 4. experiencing neurological symptoms including fatigue 5. willing to comply with all aspects of the protocol, including blood draws 6. patient is able to understand and fully participate in the activities of the study and the consent in accordance with guidelines 7. female patients of childbearing potential who are sexually active must be willing to use an acceptable form of contraception. acceptable forms of contraception are defined as those with a failure rate of < 1% when properly applied and include: a combination pill, some intra-uterine devices, and a sterilized partner in a stable relationship. female patients must not be pregnant, planning to become pregnant, or be actively breastfeeding through the entire period.

inclusion criteria: 1. age 18 and older, male or female 2. previous confirmed diagnosis of sars-cov-2 3. experiencing sars-cov-2 post-viral fatigue syndrome 4 weeks after recovery for sars-cov-2 4. experiencing neurological symptoms including fatigue 5. willing to comply with all aspects of the protocol, including blood draws 6. patient is able to understand and fully participate in the activities of the study and the consent in accordance with guidelines 7. female patients of childbearing potential who are sexually active must be willing to use an acceptable form of contraception. acceptable forms of contraception are defined as those with a failure rate of < 1% when properly applied and include: a combination pill, some intra-uterine devices, and a sterilized partner in a stable relationship. female patients must not be pregnant, planning to become pregnant, or be actively breastfeeding through the entire period.